Zyprexa news | Breaking Zyprexa news | Zyprexa

10 rock-solid stocks

...But fans like D'Amore believe strong sales of Cymbalta and other new drugs will offset declining The stock (Research) sells for 18 times trailing earnings, its lowest level since the Clintons tried to reform health care more than a decade ago, and some 20 percent below its historical average.

Yet analysts project long-term profits will grow at an above-average rate of 10 percent per year.

The stock yields 3 percent, well above the market's average yield of 1.7 percent.

D'Amore estimates shares are worth $61.

Hewlett-Packard Like Citigroup, Hewlett-Packard comes under the heading of Fallen Star.

Five years ago its shares hit their all-time high of $78.

Like all tech stocks, HP was insanely overvalued; it plummeted to $11 in 2002.

A big reason was former CEO Carly Fiorina's merger with Compaq Computer.

New CEO Mark Hurd, who took over in March after successfully turning around computer-services giant NCR, has brought an intense focus on operations.

In July, Hurd announced a major restructuring to cut billions from the company's bloated cost structure over the next few years.

The plan went well beyond layoffs - although it called for axing 10 percent of the workforce, or 15,000 jobs.

Hurd is also slashing pension benefits and realigning the sales force to give each business unit its own dedicated sales team.

The moves are...

Read more...

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | All news

Medicine   Health and Fitness